A. Maksoud

Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.

Deepak L. Bhatt, S. Saito, H. Thiele, 2021, Journal of the American College of Cardiology.

Aspirin and Clopidogrel: Efficacy, Treatment, and Resistance in Coronary Artery Disease

J. Vacek, David B. Wilson, R. Candipan, 2011 .

3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation.

Deepak L. Bhatt, S. Saito, H. Thiele, 2021, JACC. Cardiovascular interventions.

Design and Rationale of the XIENCE Short DAPT Clinical Program: an Assessment of the Safety of 3-month or 1-month DAPT in Patients at High Bleeding Risk Undergoing PCI with an Everolimus-Eluting Stent.

Deepak L. Bhatt, S. Saito, F. Neumann, 2020, American heart journal.

The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel.

Raghava R. Gollapudi, C. Grines, S. Ellis, 2017, JACC. Cardiovascular interventions.

Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow.

R. Rapoza, D. Spoon, E. Korngold, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI.

S. Bangalore, B. Vogel, S. Sartori, 2023, JACC. Cardiovascular interventions.

TCT-276 A Standardized Optical Coherence Tomography Workflow Improves Procedural Efficiency and Safety During Percutaneous Coronary Intervention: Insights From the LightLab Initiative

D. Spoon, E. Korngold, Eric Osborn, 2021, Journal of the American College of Cardiology.

Aspirin and Clopidogrel: Efficacy, Treatment, and Resistance in Coronary Artery Disease

J. Vacek, David B. Wilson, R. Candipan, 2005 .